Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth, Vascular | 4 | 2019 | 142 | 0.910 |
Why?
|
| Butyrates | 2 | 2019 | 34 | 0.660 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 61 | 0.590 |
Why?
|
| Nicotinic Acids | 1 | 2013 | 10 | 0.400 |
Why?
|
| Signal Transduction | 2 | 2019 | 2111 | 0.350 |
Why?
|
| Butyric Acid | 2 | 2007 | 19 | 0.290 |
Why?
|
| Glutathione Transferase | 2 | 2007 | 90 | 0.280 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1420 | 0.280 |
Why?
|
| Glutathione | 1 | 2007 | 170 | 0.260 |
Why?
|
| Antioxidants | 1 | 2007 | 439 | 0.210 |
Why?
|
| Rats | 5 | 2019 | 3701 | 0.200 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 92 | 0.190 |
Why?
|
| Hospital Mortality | 1 | 2020 | 206 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 297 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2019 | 1617 | 0.120 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 350 | 0.120 |
Why?
|
| Animals | 5 | 2019 | 16695 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2020 | 705 | 0.100 |
Why?
|
| Half-Life | 1 | 2013 | 63 | 0.100 |
Why?
|
| Biotransformation | 1 | 2013 | 68 | 0.100 |
Why?
|
| Hydrolysis | 1 | 2013 | 98 | 0.100 |
Why?
|
| Apoptosis | 1 | 2019 | 1541 | 0.090 |
Why?
|
| Kinetics | 1 | 2013 | 698 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 458 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1737 | 0.080 |
Why?
|
| DNA Primers | 1 | 2007 | 295 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2007 | 518 | 0.070 |
Why?
|
| HIV Infections | 1 | 2020 | 2535 | 0.060 |
Why?
|
| Base Sequence | 1 | 2007 | 997 | 0.060 |
Why?
|
| Acrolein | 1 | 2002 | 17 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 136 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2020 | 336 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 1066 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 725 | 0.030 |
Why?
|
| Humans | 2 | 2020 | 42163 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2803 | 0.030 |
Why?
|
| Male | 1 | 2013 | 22779 | 0.030 |
Why?
|
| Aorta | 2 | 2003 | 197 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 3942 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4936 | 0.020 |
Why?
|
| United States | 1 | 2020 | 5072 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 7982 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 11819 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2003 | 71 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 13458 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 149 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 195 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 314 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 310 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 103 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 82 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 105 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 100 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 100 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 649 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 452 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 266 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 462 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 534 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 594 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 1076 | 0.010 |
Why?
|
| Female | 1 | 2020 | 24018 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 973 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1265 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1848 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 990 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 1246 | 0.010 |
Why?
|